Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/11/895   
Active ingredient: Hydroxy-propyl-beta-cyclodextrin
Indication: Treatment of Niemann-Pick disease, type C
Sponsor: Medical Need Europe AB
Teatergatan 3, SE-111 48 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/09/2011 Orphan designation EMA/OD/033/11 (2011)6282 of 30/08/2011
09/03/2015 Transfer of orphan designation EMA/OD/033/11/T01 (2015)1600 of 05/03/2015